Intergroupe Francophone de Cancerologie Thoracique – Developmental Therapeutics Review – Q4 2010
Summary
Global Market Direct’s pharmaceuticals report, “Intergroupe Francophone de Cancerologie Thoracique – Developmental Therapeutics Review – Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
Reasons to buy
Summary
Global Market Direct’s pharmaceuticals report, “Intergroupe Francophone de Cancerologie Thoracique – Developmental Therapeutics Review – Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Intergroupe Francophone de Cancerologie Thoracique – Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Intergroupe Francophone de Cancerologie Thoracique human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Intergroupe Francophone de Cancerologie Thoracique with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Intergroupe Francophone de Cancerologie Thoracique’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Intergroupe Francophone de Cancerologie Thoracique’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Intergroupe Francophone de Cancerologie Thoracique in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Intergroupe Francophone de Cancerologie Thoracique’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Intergroupe Francophone de Cancerologie Thoracique.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Intergroupe Francophone de Cancerologie Thoracique and identify potential opportunities in those areas.
Intergroupe Francophone de Cancerologie Thoracique Snapshot
Key Information
Key Facts
Intergroupe Francophone de Cancerologie Thoracique – Research and Development Overview
Key Therapeutic Areas
Intergroupe Francophone de Cancerologie Thoracique – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Intergroupe Francophone de Cancerologie Thoracique – Pipeline Products Glance
Intergroupe Francophone de Cancerologie Thoracique – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Intergroupe Francophone de Cancerologie Thoracique Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Intergroupe Francophone de Cancerologie Thoracique – Drug Profiles
Docetaxel
Product Description
Mechanism of Action
R&D Progress
Docetaxel + Cisplatine
Product Description
Mechanism of Action
R&D Progress
Paclitaxel + Carboplatin
Product Description
Mechanism of Action
R&D Progress
Pazopanib
Product Description
Mechanism of Action
R&D Progress
Pemetrexed + Cisplatin + Avastin
Product Description
Mechanism of Action
R&D Progress
Pemetrexed + Cisplatin_
Product Description
Mechanism of Action
R&D Progress
erlotinib
Product Description
Mechanism of Action
R&D Progress
paclitaxel + carboplatine
Product Description
Mechanism of Action
R&D Progress
Paclitaxel, vinorelbine, cisplatin
Product Description
Mechanism of Action
R&D Progress
Intergroupe Francophone de Cancerologie Thoracique – Pipeline Analysis
Intergroupe Francophone de Cancerologie Thoracique – Pipeline Products by Therapeutic Class
Intergroupe Francophone de Cancerologie Thoracique Pipeline Products By Target
Intergroupe Francophone de Cancerologie Thoracique – Pipeline Products by Route of Administration
Intergroupe Francophone de Cancerologie Thoracique – Pipeline Products by Molecule Type
Intergroupe Francophone de Cancerologie Thoracique – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer 32
LIST OF TABLES
Intergroupe Francophone de Cancerologie Thoracique – Pipeline by Therapy Area and Indication, 2010
Intergroupe Francophone de Cancerologie Thoracique – Pipeline by Stage of Development, 2010
Intergroupe Francophone de Cancerologie Thoracique – Monotherapy Products in Pipeline, 2010
Intergroupe Francophone de Cancerologie Thoracique – Combination Treatment Modalities in Pipeline, 2010
Intergroupe Francophone de Cancerologie Thoracique – Phase III, 2010
Intergroupe Francophone de Cancerologie Thoracique - Phase II, 2010
Intergroupe Francophone de Cancerologie Thoracique - Pipeline By Therapeutic Class, 2010
Intergroupe Francophone de Cancerologie Thoracique - Pipeline By Target, 2010
Intergroupe Francophone de Cancerologie Thoracique – Pipeline By Route of Administration, 2010
Intergroupe Francophone de Cancerologie Thoracique – Pipeline By Molecule Type, 2010 29
LIST OF FIGURES
Intergroupe Francophone de Cancerologie Thoracique – Pipeline by Therapy Area and Indication, 2010
Intergroupe Francophone de Cancerologie Thoracique – Pipeline by Stage of Development, 2010
Intergroupe Francophone de Cancerologie Thoracique – Monotherapy Products in Pipeline, 2010
Intergroupe Francophone de Cancerologie Thoracique – Combination Treatment Modalities in Pipeline, 2010
Intergroupe Francophone de Cancerologie Thoracique – Pipeline By Therapeutic Class, 2010
Intergroupe Francophone de Cancerologie Thoracique - Pipeline By Target, 2010
Intergroupe Francophone de Cancerologie Thoracique – Pipeline By Route of Administration, 2010
Intergroupe Francophone de Cancerologie Thoracique – Pipeline By Molecule Type, 2010 29
Key Information
Key Facts
Intergroupe Francophone de Cancerologie Thoracique – Research and Development Overview
Key Therapeutic Areas
Intergroupe Francophone de Cancerologie Thoracique – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Intergroupe Francophone de Cancerologie Thoracique – Pipeline Products Glance
Intergroupe Francophone de Cancerologie Thoracique – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Intergroupe Francophone de Cancerologie Thoracique Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Intergroupe Francophone de Cancerologie Thoracique – Drug Profiles
Docetaxel
Product Description
Mechanism of Action
R&D Progress
Docetaxel + Cisplatine
Product Description
Mechanism of Action
R&D Progress
Paclitaxel + Carboplatin
Product Description
Mechanism of Action
R&D Progress
Pazopanib
Product Description
Mechanism of Action
R&D Progress
Pemetrexed + Cisplatin + Avastin
Product Description
Mechanism of Action
R&D Progress
Pemetrexed + Cisplatin_
Product Description
Mechanism of Action
R&D Progress
erlotinib
Product Description
Mechanism of Action
R&D Progress
paclitaxel + carboplatine
Product Description
Mechanism of Action
R&D Progress
Paclitaxel, vinorelbine, cisplatin
Product Description
Mechanism of Action
R&D Progress
Intergroupe Francophone de Cancerologie Thoracique – Pipeline Analysis
Intergroupe Francophone de Cancerologie Thoracique – Pipeline Products by Therapeutic Class
Intergroupe Francophone de Cancerologie Thoracique Pipeline Products By Target
Intergroupe Francophone de Cancerologie Thoracique – Pipeline Products by Route of Administration
Intergroupe Francophone de Cancerologie Thoracique – Pipeline Products by Molecule Type
Intergroupe Francophone de Cancerologie Thoracique – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer 32
LIST OF TABLES
Intergroupe Francophone de Cancerologie Thoracique – Pipeline by Therapy Area and Indication, 2010
Intergroupe Francophone de Cancerologie Thoracique – Pipeline by Stage of Development, 2010
Intergroupe Francophone de Cancerologie Thoracique – Monotherapy Products in Pipeline, 2010
Intergroupe Francophone de Cancerologie Thoracique – Combination Treatment Modalities in Pipeline, 2010
Intergroupe Francophone de Cancerologie Thoracique – Phase III, 2010
Intergroupe Francophone de Cancerologie Thoracique - Phase II, 2010
Intergroupe Francophone de Cancerologie Thoracique - Pipeline By Therapeutic Class, 2010
Intergroupe Francophone de Cancerologie Thoracique - Pipeline By Target, 2010
Intergroupe Francophone de Cancerologie Thoracique – Pipeline By Route of Administration, 2010
Intergroupe Francophone de Cancerologie Thoracique – Pipeline By Molecule Type, 2010 29
LIST OF FIGURES
Intergroupe Francophone de Cancerologie Thoracique – Pipeline by Therapy Area and Indication, 2010
Intergroupe Francophone de Cancerologie Thoracique – Pipeline by Stage of Development, 2010
Intergroupe Francophone de Cancerologie Thoracique – Monotherapy Products in Pipeline, 2010
Intergroupe Francophone de Cancerologie Thoracique – Combination Treatment Modalities in Pipeline, 2010
Intergroupe Francophone de Cancerologie Thoracique – Pipeline By Therapeutic Class, 2010
Intergroupe Francophone de Cancerologie Thoracique - Pipeline By Target, 2010
Intergroupe Francophone de Cancerologie Thoracique – Pipeline By Route of Administration, 2010
Intergroupe Francophone de Cancerologie Thoracique – Pipeline By Molecule Type, 2010 29
